For U.S. Full Product Information including WARNINGS regarding allergic reactions and heart attack click here.

ERBITUX® is a registered trademark of ImClone Systems Incorporated. ImClone Systems Incorporated has granted to Merck KGaA, Darmstadt, Germany, exclusive rights to develop and commercialize ERBITUX outside of the United States and Canada and co-exclusive rights to develop ERBITUX in Japan.

©2008, ImClone Systems Incorporated, New York, NY 10014, U.S.A.; Bristol-Myers Squibb Company, Princeton, NJ 08543, U.S.A.; Merck KGaA, Darmstadt, Germany.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.